Health Care · Health Care Equipment
Dexcom: revenue, profit and cash flow
In fiscal 2025, Dexcom had revenue of $4.66B, up 27.8% a year on average since 2015, and net income of $836M (17.9% of revenue). It has 27% more shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +15.6% vs 2024
- Ticker
- DXCM · Nasdaq
- Sector
- Health Care
- Sub-industry
- Health Care Equipment
- Headquarters
- San Diego, California
- Founded
- 1999
- In the S&P 500 since
- May 12, 2020
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Dexcom Inc · CIK 0001093557
Revenue and net income
Revenue went from $29.7M in 2009 to $4.66B in 2025. Net loss in 2009–2018.
Diluted earnings per share
Diluted EPS went from −$0.30 in 2009 to $2.09 in 2025.
Shares outstanding
27.0% more shares in 2025 than in 2015 (319M → 406M): new shares outweighed buybacks.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $1.08B in 2025, 23.1% of revenue. Negative in 2009–2013.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|
| 2025 | $4.66B | $836M | 17.9% | $2.09 | 406M | $1.44B | $364M | $1.08B |
| 2024 | $4.03B | $576M | 14.3% | $1.42 | 413M | $990M | $359M | $631M |
| 2023 | $3.62B | $542M | 14.9% | $1.30 | 426M | $748M | $237M | $512M |
| 2022 | $2.91B | $341M | 11.7% | $0.82 | 428M | $670M | $365M | $305M |
| 2021 | $2.45B | $217M | 8.9% | $0.53 | 429M | $442M | $389M | $53.3M |
| 2020 | $1.93B | $550M | 28.5% | $1.33 | 420M | $476M | $199M | $277M |
| 2019 | $1.48B | $101M | 6.8% | $0.28 | 369M | $314M | $180M | $134M |
| 2018 | $1.03B | −$127M | −12.3% | −$0.36 | 353M | $123M | $67.1M | $56.1M |
| 2017 | $718M | −$50.2M | −7.0% | −$0.14 | 345M | $92M | $66M | $26M |
| 2016 | $573M | −$65.6M | −11.4% | −$0.20 | 334M | $56.2M | $55.7M | $500K |
| 2015 | $402M | −$57.6M | −14.3% | −$0.18 | 319M | $49M | $33.3M | $15.7M |
| 2014 | $259M | −$22.4M | −8.6% | −$0.07 | 301M | $23.6M | $16.2M | $7.4M |
| 2013 | $160M | −$29.8M | −18.6% | −$0.10 | 284M | $2.4M | $7.9M | −$5.5M |
| 2012 | $99.9M | −$54.5M | −54.6% | −$0.20 | 275M | −$33.1M | $9.5M | −$42.6M |
| 2011 | $76.3M | −$44.7M | −58.6% | −$0.17 | 262M | −$30.1M | $8.0M | −$38.1M |
| 2010 | $48.6M | −$55.2M | −113.6% | −$0.24 | 228M | −$42.7M | $6.9M | −$49.6M |
| 2009 | $29.7M | −$53.5M | −180.3% | −$0.30 | — | −$39.4M | $2.99M | −$42.4M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
Stock splits
Found in the filings; per-share figures and share counts on this page are on today’s share basis.
- 4-for-1 split · first reflected in a filing of July 28, 2022
About these figures
- No dividends per share in the filings data. Usually that means no dividend, but some companies report theirs in a form the data do not capture.
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Equipment companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.